369 related articles for article (PubMed ID: 36883945)
1. The Bidirectional Gut-Lung Axis in Chronic Obstructive Pulmonary Disease.
Wang L; Cai Y; Garssen J; Henricks PAJ; Folkerts G; Braber S
Am J Respir Crit Care Med; 2023 May; 207(9):1145-1160. PubMed ID: 36883945
[TBL] [Abstract][Full Text] [Related]
2. Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A review.
Song W; Yue Y; Zhang Q
Biomed Pharmacother; 2023 Sep; 165():115150. PubMed ID: 37429232
[TBL] [Abstract][Full Text] [Related]
3. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease.
Lim EY; Song EJ; Shin HS
J Microbiol Biotechnol; 2023 Sep; 33(9):1111-1118. PubMed ID: 37164760
[TBL] [Abstract][Full Text] [Related]
5. Lung microbiome, gut-lung axis and chronic obstructive pulmonary disease.
Gokulan K; Joshi M; Khare S; Bartter T
Curr Opin Pulm Med; 2022 Mar; 28(2):134-138. PubMed ID: 34907959
[TBL] [Abstract][Full Text] [Related]
6. The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota.
Jia Y; He T; Wu D; Tong J; Zhu J; Li Z; Dong J
J Transl Med; 2022 Jun; 20(1):281. PubMed ID: 35729584
[TBL] [Abstract][Full Text] [Related]
7. Dysbiosis of Gut Microbiota and Intestinal Barrier Dysfunction in Pigs with Pulmonary Inflammation Induced by Mycoplasma hyorhinis Infection.
Zhang Y; Gan Y; Wang J; Feng Z; Zhong Z; Bao H; Xiong Q; Wang R
mSystems; 2022 Aug; 7(4):e0028222. PubMed ID: 35699454
[TBL] [Abstract][Full Text] [Related]
8. Gut-lung Microbiota Interactions in Chronic Obstructive Pulmonary Disease (COPD): Potential Mechanisms Driving Progression to COPD and Epidemiological Data.
De Nuccio F; Piscitelli P; Toraldo DM
Lung; 2022 Dec; 200(6):773-781. PubMed ID: 36241745
[TBL] [Abstract][Full Text] [Related]
9. Microbiome Links Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease and Dietary Fiber via the Gut-Lung Axis: A Narrative Review.
Ding K; Chen J; Zhan W; Zhang S; Chen Y; Long S; Lei M
COPD; 2021 Dec; 19(1):10-17. PubMed ID: 34963421
[TBL] [Abstract][Full Text] [Related]
10. Gut-Lung Microbiota Interaction in COPD Patients: A Literature Review.
Krumina A; Bogdanova M; Gintere S; Viksna L
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556962
[TBL] [Abstract][Full Text] [Related]
11. The role of gut-lung axis in COPD: Pathogenesis, immune response, and prospective treatment.
Song Z; Meng Y; Fricker M; Li X; Tian H; Tan Y; Qin L
Heliyon; 2024 May; 10(9):e30612. PubMed ID: 38742057
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory
Lai HC; Lin TL; Chen TW; Kuo YL; Chang CJ; Wu TR; Shu CC; Tsai YH; Swift S; Lu CC
Gut; 2022 Feb; 71(2):309-321. PubMed ID: 33687943
[TBL] [Abstract][Full Text] [Related]
13. Association of Intestinal Microbial Dysbiosis With Chronic Obstructive Pulmonary Disease.
Ananya FN; Ahammed MR; Fahem MM; Kafle S; Viswanathan M; Desai D; Akku R; Khan F; Hernandez TE; Bala SK; Gulati S; Martin N; Yatzkan GD; Pérez-Fernández J
Cureus; 2021 Nov; 13(11):e19343. PubMed ID: 34909304
[TBL] [Abstract][Full Text] [Related]
14. The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats.
Mao J; Li Y; Bian Q; Xuan Y; Li J; Wang Z; Feng S; Liu X; Tian Y; Li S
Int J Chron Obstruct Pulmon Dis; 2022; 17():1285-1298. PubMed ID: 35673595
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiome and Transcriptomic Changes in Cigarette Smoke-Exposed Mice Compared to COPD and CD Patient Datasets.
Wang L; Koelink PJ; Garssen J; Folkerts G; Henricks PAJ; Braber S
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612871
[TBL] [Abstract][Full Text] [Related]
16. Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases.
Liu X; Wang X; Zhang P; Fang Y; Liu Y; Ding Y; Zhang W
Front Immunol; 2023; 14():1266792. PubMed ID: 38022571
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota, in the Halfway between Nutrition and Lung Function.
Espírito Santo C; Caseiro C; Martins MJ; Monteiro R; Brandão I
Nutrients; 2021 May; 13(5):. PubMed ID: 34069415
[TBL] [Abstract][Full Text] [Related]
18. Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease.
Kotlyarov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563159
[TBL] [Abstract][Full Text] [Related]
19. Seabuckthorn Wuwei Pulvis attenuates chronic obstructive pulmonary disease in rat through gut microbiota-short chain fatty acids axis.
Wang J; Ren C; Jin L; Batu W
J Ethnopharmacol; 2023 Oct; 314():116591. PubMed ID: 37146846
[TBL] [Abstract][Full Text] [Related]
20. Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review.
Zhao M; Chu J; Feng S; Guo C; Xue B; He K; Li L
Biomed Pharmacother; 2023 Aug; 164():114985. PubMed ID: 37311282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
